IPQ Final | Page 8

Monthly Update/ September 2023

www.ipq.org

Monthly Update/Article

7

While expressing strong backing for the environmental/green goals that Europe is pursuing, industry is proposing that the same scientific evidence and benefit-risk principles critical in other aspects of medicines evaluation should be deployed in ensuring that safe, high-quality medicines remain available and can still be manufactured in Europe.

Industry is Urging EMA to Increase its Focus on Medicine Impact of EU Food

News in depth

The European Federation of Pharmaceutical Industries and Associations (EFPIA) is stressing that food, chemical, and environmental legislation should be developed and implemented with the impact on medicines in mind and that EMA and other regulatory authorities and stakeholders need to be more directly engaged to make sure that the outcomes align with the EU’s healthcare objectives.

environmental/green goals that Europe is pursuing,

September 2023